查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1587467

小分子 API 連續製造市場規模、佔有率、趨勢分析報告：按設備、按單元操作、按類型、按最終用途、按地區、細分市場預測，2024-2030 年

Continuous Manufacturing For Small Molecule APIs Market Size, Share & Trends Analysis Report By Equipment (Reactors, Crystallizers, Filtration Systems), By Unit Operation, By Type, By End Use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

小分子 API 連續製造市場成長與趨勢：

Grand View Research, Inc.的研究報告顯示，到2030年，全球小分子API連續製造市場規模預計將達到67,152萬美元，2024年至2030年複合年成長率為10.42%。

這種強勁的擴張得益於反映當前行業趨勢、技術進步和監管環境變化的幾個關鍵促進因素。連續製造流程與傳統批量加工相比具有顯著優勢，包括提高效率、降低製造成本和提高產品品質。美國食品藥物管理局(FDA) 認知到其在簡化藥品生產流程和提高整體藥品品質方面的潛力，積極推廣連續生產技術。例如，FDA 的 21 世紀藥品品質計畫已將連續生產確定為重點關注領域，並鼓勵公司採用這些創新方法來更好地控制生產變數。

最近的技術進步進一步推動了連續製造市場的發展。製程分析技術 (PAT) 的創新可即時監控生產流程，確保品質穩定並符合監管標準。例如，2024 年 7 月，GEA 宣布了一項新的連續加工技術，旨在提高藥品製造的靈活性和效率。在 ACHEMA 2024 上，GEA 展示了與 Hobione 的合作，重點介紹了 ConsiGma CDC Flex 系統。該系統支援各種吞吐量的連續和批量流程，從而提高生產品質和永續性。這些技術不僅提高了效率，還大大縮短了新藥的上市時間，使其成為競爭日益激烈的製藥行業的重要組成部分。

政府的舉措和支持在連續製造市場的成長中也發揮著重要作用。各國已經認知到需要實現藥品製造現代化，以增強競爭力並改善公共衛生成果。例如，美國政府推出了旨在加速採用連續製造技術的計劃，提供資金和資源來支持產業內的創新。同樣，歐洲藥品管理局 (EMA) 推廣指導方針，以加速歐洲製藥業採用這些技術，並鼓勵使用連續流程。

小分子 API 連續製造市場報告亮點

  • 從設備來看，反應器將在 2023 年以 35.2% 的顯著佔有率主導市場，預計在預測期內將以 11.0% 的複合年成長率成長最快。
  • 從設備來看，到 2023 年，合成設備將佔據最大的銷售佔有率，達到 39.1%，並且在技術進步、效率提升和向永續實踐轉變的推動下，預計未來幾年將繼續擴大。
  • 按類型分類，非專利原料藥佔市場主導地位，2023 年收益佔有率高達 10.8%。
  • 按最終用途分類，CMO/CDMO 佔據市場主導地位，到 2023 年將佔據 70.2% 的巨大收益佔有率。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第 3 章小分子 API 連續製造市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 小分子API連續製造市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章小分子原料藥連續生產市場：設備估算及趨勢分析

  • 小分子 API 連續製造的全球市場：設備儀表板
  • 全球小分子原料藥連續生產市場：設備波動分析
  • 全球小分子 API 連續生產市場：按設備分類的收益
  • 核子反應爐
  • 結晶設備
  • 過濾系統
  • 攪拌機
  • 熱交換器
  • 其他（烘乾機等）

第5章 小分子原料藥連續生產市場：裝置運作預測及趨勢分析

  • 小分子 API 連續製造的全球市場：單元操作儀表板
  • 全球小分子原料藥連續生產市場：單元操作變化分析
  • 按單位營運收益
  • 合成
  • 分離精製
  • 烘乾

第6章 小分子原料藥連續生產市場：類型估計與趨勢分析

  • 小分子 API 連續製造的全球市場：類型儀表板
  • 小分子 API 連續生產的全球市場：類型變異分析
  • 按類型分類的收益
  • 一般API
  • 創新的API

第7章 小分子 API 連續製造市場：最終用途估計與趨勢分析

  • 小分子 API 連續製造的全球市場：最終用途儀表板
  • 小分子 API 連續製造的全球市場：最終用途變化分析
  • 按最終用途分類的收益
  • CMO/CDMO
  • 製藥公司
  • 學術研究所

第 8 章小分子 API 連續製造市場：按設備、單元操作、類型和最終用途進行的區域估計和趨勢分析

  • 區域儀表板
  • 2018-2030年市場規模、預測趨勢分析：
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭格局

  • 公司/競爭對手分類
  • 供應商情況
    • 主要經銷商及通路夥伴名單
    • Key company market share analysis, 2023
    • Pfizer Inc
    • GSK plc.（GlaxoSmithKline）
    • Vertex Pharmaceuticals Incorporated
    • Janssen（a subsidiary of Johnson &Johnson）
    • Abbvie Inc.
    • Sterling Pharma Solutions
    • Evonik Industries AG
    • Cambrex Corporation
    • Patheon
    • Hovione
    • Lonza
    • Phlow
    • Asymchem
    • GEA Group AG
    • Thermo Fisher Scientific
    • Corning Incorporated
    • Coperion GmbH
    • Continuus Pharmaceuticals
    • Chemtrix
    • Vapourtec Ltd
    • Ehrfeld Mikrotechnik GmbH
    • NiTech Solutions Ltd
Product Code: GVR-4-68040-472-6

Continuous Manufacturing For Small Molecule APIs Market Growth & Trends:

The global continuous manufacturing for small molecule APIs market size is anticipated to reach USD 671.52 million by 2030, growing at a CAGR of 10.42% from 2024 to 2030, according to a report by Grand View Research, Inc. This robust expansion can be attributed to several key drivers that reflect current industry trends, advancements in technology, and changing regulatory landscapes. Continuous manufacturing processes offer significant advantages over traditional batch processing, including increased efficiency, reduced production costs, and improved product quality. The United States Food and Drug Administration (FDA) has actively promoted continuous manufacturing technologies, recognizing their potential to streamline the drug production process and enhance the overall quality of pharmaceutical products. For instance, the FDA's "Pharmaceutical Quality for the 21st Century" initiative highlights continuous manufacturing as a key focus area, encouraging companies to adopt these innovative approaches to ensure better control over production variables.

Recent technological advancements further propel the continuous manufacturing market. Innovations in process analytical technology (PAT) enable real-time monitoring of production processes, ensuring consistent quality and compliance with regulatory standards. For instance, in July 2024, GEA introduced new continuous processing technologies designed to enhance flexibility and efficiency in pharmaceutical manufacturing. At ACHEMA 2024, GEA showcased its collaboration with Hovione, emphasizing the ConsiGma CDC flex system. This system supports both continuous and batch processes with varied throughput, improving production quality and sustainability. Their partnership aims to simplify operations and make continuous manufacturing more accessible across the industry.These technologies not only increase efficiency but also significantly shorten time-to-market for new drugs, an essential factor in an increasingly competitive pharmaceutical industry.

Government initiatives and support also play a crucial role in the growth of the continuous manufacturing market. Various countries are recognizing the need for modernization in pharmaceutical manufacturing to enhance competitiveness and improve public health outcomes. For example, the U.S. government has introduced programs aimed at facilitating the adoption of continuous manufacturing technologies, providing funding and resources to support innovation within the industry. Similarly, the European Medicines Agency (EMA) has been encouraging the use of continuous processes, promoting guidelines that facilitate the implementation of these technologies within Europe's pharmaceutical sector.

Continuous Manufacturing For Small Molecule APIs Market Report Highlights:

  • Based on equipment, reactors dominated the market with a substantial share of 35.2% in 2023 and are expected to grow at the fastest CAGR of 11.0% during the forecast period
  • Based on unit operation, the synthesis segment held the largest revenue share of 39.1% in 2023 driven by technological advancements, efficiency gains, and a shift toward sustainable practices, positioning it for continued expansion in the coming years
  • Based on type, generic APIs dominated the market, capturing a substantial revenue share of 10.8% in 2023
  • Based on end use, CMO/CDMOs dominated the market, capturing a substantial revenue share of 70.2% in 2023

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Equipment
    • 1.2.2. Unit Operation
    • 1.2.3. Type
    • 1.2.4. End Use
    • 1.2.5. Regional scope
    • 1.2.6. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Equipment Outlook
    • 2.2.2. Unit Operation
    • 2.2.3. Type
    • 2.2.4. End Use
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Continuous Manufacturing for Small Molecule APIs Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rapid growth in the global pharmaceutical industry
      • 3.2.1.2. Growing role of flow chemistry in API manufacturing
      • 3.2.1.3. Growing adoption and improved efficiency & productivity
      • 3.2.1.4. Emergence as a green, sustainable and profitable process technology
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High R&D investment and capital cost
      • 3.2.2.2. Regulatory compliance and process validation
  • 3.3. Continuous Manufacturing for Small Molecule APIs Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Continuous Manufacturing for Small Molecule APIs Market: Equipment Estimates & Trend Analysis

  • 4.1. Global Continuous Manufacturing for Small Molecule APIs Market: Equipment Dashboard
  • 4.2. Global Continuous Manufacturing for Small Molecule APIs Market: Equipment Movement Analysis
  • 4.3. Global Continuous Manufacturing for Small Molecule APIs Market by Equipment, Revenue
  • 4.4. Reactors
    • 4.4.1. Reactors market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Crystallizers
    • 4.5.1. Crystallizers market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Filtration Systems
    • 4.6.1. Filtration Systems market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Mixers
    • 4.7.1. Mixers market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Heat Exchangers
    • 4.8.1. Heat Exchangers market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.9. Others (Dryers, etc.)
    • 4.9.1. Others (Dryers, etc.) market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Continuous Manufacturing for Small Molecule APIs Market: Unit Operation Estimates & Trend Analysis

  • 5.1. Global Continuous Manufacturing for Small Molecule APIs Market: Unit Operation Dashboard
  • 5.2. Global Continuous Manufacturing for Small Molecule APIs Market: Unit Operation Movement Analysis
  • 5.3. Global Continuous Manufacturing for Small Molecule APIs Market Estimates and Forecasts, By Unit Operation, Revenue (USD Million)
  • 5.4. Synthesis
    • 5.4.1. Synthesis market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Separation & Purification
    • 5.5.1. Separation & Purification market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Drying
    • 5.6.1. Drying market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Continuous Manufacturing for Small Molecule APIs Market: Type Estimates & Trend Analysis

  • 6.1. Global Continuous Manufacturing for Small Molecule APIs Market: Type Dashboard
  • 6.2. Global Continuous Manufacturing for Small Molecule APIs Market: Type Movement Analysis
  • 6.3. Global Continuous Manufacturing for Small Molecule APIs Market Estimates and Forecasts, By Type, Revenue (USD Million)
  • 6.4. Generic APIs
    • 6.4.1. Generic APIs market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Innovative APIs
    • 6.5.1. Innovative APIs market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Continuous Manufacturing for Small Molecule APIs Market: End Use Estimates & Trend Analysis

  • 7.1. Global Continuous Manufacturing for Small Molecule APIs Market: End Use Dashboard
  • 7.2. Global Continuous Manufacturing for Small Molecule APIs Market: End Use Movement Analysis
  • 7.3. Global Continuous Manufacturing for Small Molecule APIs Market Estimates and Forecasts, By End Use, Revenue (USD Million)
  • 7.4. CMOs/CDMOs
    • 7.4.1. CMOs/CDMOs market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Pharmaceutical Companies
    • 7.5.1. Pharmaceutical Companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Academic & Research Institutes
    • 7.6.1. Academic & Research Institutes market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Continuous Manufacturing for Small Molecule APIs Market: Regional Estimates & Trend Analysis by Equipment, Unit Operation, Type and End Use

  • 8.1. Regional Dashboard
  • 8.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.3. North America
    • 8.3.1. U.S.
      • 8.3.1.1. Key country dynamics
      • 8.3.1.2. Regulatory framework/ reimbursement structure
      • 8.3.1.3. Competitive scenario
      • 8.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.3.2. Canada
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Regulatory framework/ reimbursement structure
      • 8.3.2.3. Competitive scenario
      • 8.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.3.3. Mexico
      • 8.3.3.1. Key country dynamics
      • 8.3.3.2. Regulatory framework/ reimbursement structure
      • 8.3.3.3. Competitive scenario
      • 8.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. UK
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Regulatory framework/ reimbursement structure
      • 8.4.1.3. Competitive scenario
      • 8.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework/ reimbursement structure
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.3. France
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework/ reimbursement structure
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.4. Italy
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Regulatory framework/ reimbursement structure
      • 8.4.4.3. Competitive scenario
      • 8.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.5. Spain
      • 8.4.5.1. Key country dynamics
      • 8.4.5.2. Regulatory framework/ reimbursement structure
      • 8.4.5.3. Competitive scenario
      • 8.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.6. Norway
      • 8.4.6.1. Key country dynamics
      • 8.4.6.2. Regulatory framework/ reimbursement structure
      • 8.4.6.3. Competitive scenario
      • 8.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.7. Sweden
      • 8.4.7.1. Key country dynamics
      • 8.4.7.2. Regulatory framework/ reimbursement structure
      • 8.4.7.3. Competitive scenario
      • 8.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.8. Denmark
      • 8.4.8.1. Key country dynamics
      • 8.4.8.2. Regulatory framework/ reimbursement structure
      • 8.4.8.3. Competitive scenario
      • 8.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Japan
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework/ reimbursement structure
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2. China
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3. India
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework/ reimbursement structure
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.4. Australia
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework/ reimbursement structure
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework/ reimbursement structure
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework/ reimbursement structure
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Brazil
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework/ reimbursement structure
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2. Argentina
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. MEA
    • 8.7.1. South Africa
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework/ reimbursement structure
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2. Saudi Arabia
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework/ reimbursement structure
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.4. Kuwait
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework/ reimbursement structure
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Vendor Landscape
    • 9.2.1. List of key distributors and channel partners
    • 9.2.2. Key company market share analysis, 2023
    • 9.2.3. Pfizer Inc
      • 9.2.3.1. Company overview
      • 9.2.3.2. Financial performance
      • 9.2.3.3. Equipment benchmarking
      • 9.2.3.4. Strategic initiatives
    • 9.2.4. GSK plc. (GlaxoSmithKline)
      • 9.2.4.1. Company overview
      • 9.2.4.2. Financial performance
      • 9.2.4.3. Equipment benchmarking
      • 9.2.4.4. Strategic initiatives
    • 9.2.5. Vertex Pharmaceuticals Incorporated
      • 9.2.5.1. Company overview
      • 9.2.5.2. Financial performance
      • 9.2.5.3. Equipment benchmarking
      • 9.2.5.4. Strategic initiatives
    • 9.2.6. Janssen (a subsidiary of Johnson & Johnson)
      • 9.2.6.1. Company overview
      • 9.2.6.2. Financial performance
      • 9.2.6.3. Equipment benchmarking
      • 9.2.6.4. Strategic initiatives
    • 9.2.7. Abbvie Inc.
      • 9.2.7.1. Company overview
      • 9.2.7.2. Financial performance
      • 9.2.7.3. Equipment benchmarking
      • 9.2.7.4. Strategic initiatives
    • 9.2.8. Sterling Pharma Solutions
      • 9.2.8.1. Company overview
      • 9.2.8.2. Financial performance
      • 9.2.8.3. Equipment benchmarking
      • 9.2.8.4. Strategic initiatives
    • 9.2.9. Evonik Industries AG
      • 9.2.9.1. Company overview
      • 9.2.9.2. Financial performance
      • 9.2.9.3. Equipment benchmarking
      • 9.2.9.4. Strategic initiatives
    • 9.2.10. Cambrex Corporation
      • 9.2.10.1. Company overview
      • 9.2.10.2. Financial performance
      • 9.2.10.3. Equipment benchmarking
      • 9.2.10.4. Strategic initiatives
    • 9.2.11. Patheon
      • 9.2.11.1. Company overview
      • 9.2.11.2. Financial performance
      • 9.2.11.3. Equipment benchmarking
      • 9.2.11.4. Strategic initiatives
    • 9.2.12. Hovione
      • 9.2.12.1. Company overview
      • 9.2.12.2. Financial performance
      • 9.2.12.3. Equipment benchmarking
      • 9.2.12.4. Strategic initiatives
    • 9.2.13. Lonza
      • 9.2.13.1. Company overview
      • 9.2.13.2. Financial performance
      • 9.2.13.3. Equipment benchmarking
      • 9.2.13.4. Strategic initiatives
    • 9.2.14. Phlow
      • 9.2.14.1. Company overview
      • 9.2.14.2. Financial performance
      • 9.2.14.3. Equipment benchmarking
      • 9.2.14.4. Strategic initiatives
    • 9.2.15. Asymchem
      • 9.2.15.1. Company overview
      • 9.2.15.2. Financial performance
      • 9.2.15.3. Equipment benchmarking
      • 9.2.15.4. Strategic initiatives
    • 9.2.16. GEA Group AG
      • 9.2.16.1. Company overview
      • 9.2.16.2. Financial performance
      • 9.2.16.3. Equipment benchmarking
      • 9.2.16.4. Strategic initiatives
    • 9.2.17. Thermo Fisher Scientific
      • 9.2.17.1. Company overview
      • 9.2.17.2. Financial performance
      • 9.2.17.3. Equipment benchmarking
      • 9.2.17.4. Strategic initiatives
    • 9.2.18. Corning Incorporated
      • 9.2.18.1. Company overview
      • 9.2.18.2. Financial performance
      • 9.2.18.3. Equipment benchmarking
      • 9.2.18.4. Strategic initiatives
    • 9.2.19. Coperion GmbH
      • 9.2.19.1. Company overview
      • 9.2.19.2. Financial performance
      • 9.2.19.3. Equipment benchmarking
      • 9.2.19.4. Strategic initiatives
    • 9.2.20. Continuus Pharmaceuticals
      • 9.2.20.1. Company overview
      • 9.2.20.2. Financial performance
      • 9.2.20.3. Equipment benchmarking
      • 9.2.20.4. Strategic initiatives
    • 9.2.21. Chemtrix
      • 9.2.21.1. Company overview
      • 9.2.21.2. Financial performance
      • 9.2.21.3. Equipment benchmarking
      • 9.2.21.4. Strategic initiatives
    • 9.2.22. Vapourtec Ltd
      • 9.2.22.1. Company overview
      • 9.2.22.2. Financial performance
      • 9.2.22.3. Equipment benchmarking
      • 9.2.22.4. Strategic initiatives
    • 9.2.23. Ehrfeld Mikrotechnik GmbH
      • 9.2.23.1. Company overview
      • 9.2.23.2. Financial performance
      • 9.2.23.3. Equipment benchmarking
      • 9.2.23.4. Strategic initiatives
    • 9.2.24. NiTech Solutions Ltd
      • 9.2.24.1. Company overview
      • 9.2.24.2. Financial performance
      • 9.2.24.3. Equipment benchmarking
      • 9.2.24.4. Strategic initiatives

List of Tables

  • Table 1 List Of Abbreviation
  • Table 2 North America Continuous Manufacturing for Small Molecule APIs Market, By Region, 2018 - 2030 (USD Million)
  • Table 3 North America Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 4 North America Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 5 North America Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 6 North America Continuous Manufacturing for Small Molecule APIs Market, End Use, 2018 - 2030 (USD Million)
  • Table 7 U.S. Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 8 U.S. Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 9 U.S. Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 10 U.S. Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 11 Canada Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 12 Canada Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 13 Canada Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 14 Canada Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 15 Mexico Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 16 Mexico Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 17 Mexico Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 18 Mexico Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 19 Europe Continuous Manufacturing for Small Molecule APIs Market, By Region, 2018 - 2030 (USD Million)
  • Table 20 Europe Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 21 Europe Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 22 Europe Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 23 Europe Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 24 Germany Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 25 Germany Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 26 Germany Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 27 Germany Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 28 UK Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 29 UK Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 30 UK Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 31 UK Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 32 France Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 33 France Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 34 France Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 35 France Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 36 Italy Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 37 Italy Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 38 Italy Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 39 Italy Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 40 Spain Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 41 Spain Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 42 Spain Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 43 Spain Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 44 Denmark Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 45 Denmark Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 46 Denmark Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 47 Denmark Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 48 Sweden Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 49 Sweden Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 50 Sweden Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 51 Sweden Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 52 Norway Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 53 Norway Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 54 Norway Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 55 Norway Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific Continuous Manufacturing for Small Molecule APIs Market, By Region, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 61 China Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 62 China Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 63 China Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 64 China Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 65 Japan Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 66 Japan Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 67 Japan Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 68 Japan Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 69 India Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 70 India Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 71 India Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 72 India Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 73 South Korea Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 74 South Korea Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 75 South Korea Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 76 South Korea Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 77 Australia Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 78 Australia Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 79 Australia Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 80 Australia Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 81 Thailand Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 82 Thailand Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 83 Thailand Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 84 Thailand Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 85 Latin America Continuous Manufacturing for Small Molecule APIs Market, By Region, 2018 - 2030 (USD Million)
  • Table 86 Latin America Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 87 Latin America Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 88 Latin America Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 89 Latin America Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 90 Brazil Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 91 Brazil Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 92 Brazil Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 93 Brazil Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 94 Argentina Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 95 Argentina Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 96 Argentina Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 97 Argentina Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 98 MEA Continuous Manufacturing for Small Molecule APIs Market, By Region, 2018 - 2030 (USD Million)
  • Table 99 MEA Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 100 MEA Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 101 MEA Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 102 MEA Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 103 South Africa Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 104 South Africa Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 105 South Africa Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 106 South Africa Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 110 Saudi Arabia Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 111 UAE Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 112 UAE Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 113 UAE Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 114 UAE Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 115 Kuwait Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 116 Kuwait Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 117 Kuwait Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 118 Kuwait Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Continuous Manufacturing for Small Molecule APIs Market: Market Outlook
  • Fig. 14 Colorectal Surgery Competitive Insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Continuous Manufacturing for Small Molecule APIs Market Driver Impact
  • Fig. 18 Continuous Manufacturing for Small Molecule APIs Market Restraint Impact
  • Fig. 19 Continuous Manufacturing for Small Molecule APIs Market Strategic Initiatives Analysis
  • Fig. 20 Continuous Manufacturing for Small Molecule APIs Market: Equipment Movement Analysis
  • Fig. 21 Continuous Manufacturing for Small Molecule APIs Market: Equipment Outlook And Key Takeaways
  • Fig. 22 Reactors market estimates and forecast, 2018 - 2030
  • Fig. 23 Crystallizers market estimates and forecast, 2018 - 2030
  • Fig. 24 Filtration Systems market estimates and forecast, 2018 - 2030
  • Fig. 25 Mixers market estimates and forecast, 2018 - 2030
  • Fig. 26 Heat Exchangers market estimates and forecast, 2018 - 2030
  • Fig. 27 Others (Dryers, etc.) market estimates and forecast, 2018 - 2030
  • Fig. 28 Continuous Manufacturing for Small Molecule APIs Market: Unit Operation Movement Analysis
  • Fig. 29 Continuous Manufacturing for Small Molecule APIs Market: Unit Operation Outlook And Key Takeaways
  • Fig. 30 Synthesis market estimates and forecast, 2018 - 2030
  • Fig. 31 Separation & Purification Separation & Purification market estimates and forecast, 2018 - 2030
  • Fig. 32 Continuous Manufacturing for Small Molecule APIs Market: Type Movement Analysis
  • Fig. 33 Continuous Manufacturing for Small Molecule APIs Market: Type Outlook And Key Takeaways
  • Fig. 34 Generic APIs market estimates and forecast, 2018 - 2030
  • Fig. 35 Innovative APIs market estimates and forecast, 2018 - 2030
  • Fig. 36 Continuous Manufacturing for Small Molecule APIs Market: End Use Movement Analysis
  • Fig. 37 Continuous Manufacturing for Small Molecule APIs Market: End Use Outlook And Key Takeaways
  • Fig. 38 CMOs/CDMOs market estimates and forecast, 2018 - 2030
  • Fig. 39 Pharmaceutical Companies market estimates and forecast, 2018 - 2030
  • Fig. 40 Academic & Research Institutes market estimates and forecast, 2018 - 2030
  • Fig. 41 Global Continuous Manufacturing for Small Molecule APIs Market: Regional Movement Analysis
  • Fig. 42 Global Continuous Manufacturing for Small Molecule APIs Market: Regional Outlook And Key Takeaways
  • Fig. 43 Global Continuous Manufacturing for Small Molecule APIs Market share and leading players
  • Fig. 44 North America, by country
  • Fig. 45 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 U.S. key country dynamics
  • Fig. 47 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Canada key country dynamics
  • Fig. 49 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Mexico key country dynamics
  • Fig. 51 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 UK key country dynamics
  • Fig. 54 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Germany key country dynamics
  • Fig. 56 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 France key country dynamics
  • Fig. 58 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Italy key country dynamics
  • Fig. 60 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Spain key country dynamics
  • Fig. 62 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Denmark key country dynamics
  • Fig. 64 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Sweden key country dynamics
  • Fig. 66 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Norway key country dynamics
  • Fig. 68 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 China key country dynamics
  • Fig. 71 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Japan key country dynamics
  • Fig. 73 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 India key country dynamics
  • Fig. 75 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Thailand key country dynamics
  • Fig. 77 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 South Korea key country dynamics
  • Fig. 79 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Australia key country dynamics
  • Fig. 81 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Brazil key country dynamics
  • Fig. 84 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Argentina key country dynamics
  • Fig. 86 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 South Africa key country dynamics
  • Fig. 89 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 Saudi Arabia key country dynamics
  • Fig. 91 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 UAE key country dynamics
  • Fig. 93 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 Kuwait key country dynamics
  • Fig. 95 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 Market share of key market players- Continuous Manufacturing for Small Molecule APIs Market